Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, February 21st. Shareholders of record on Friday, March 31st will be given a dividend of 0.14 per share by the conglomerate on Friday, April 28th. This represents a $0.56 annualized dividend and a yield of 0.65%. The ex-dividend date is Wednesday, March 29th. This is a boost from Danaher’s previous quarterly dividend of $0.13.
Danaher has increased its dividend payment by an average of 97.8% annually over the last three years and has raised its dividend annually for the last 3 consecutive years. Danaher has a dividend payout ratio of 14.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Danaher to earn $4.31 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 13.0%.
Danaher (NYSE:DHR) traded down 3.985% during trading on Thursday, reaching $82.995. The company’s stock had a trading volume of 7,320,445 shares. Danaher has a 52 week low of $71.99 and a 52 week high of $102.79. The firm has a market cap of $57.54 billion, a P/E ratio of 22.726 and a beta of 1.00. The stock’s 50 day moving average is $86.34 and its 200-day moving average is $81.55.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, April 20th. The conglomerate reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.01. The firm earned $4.21 billion during the quarter, compared to analyst estimates of $4.17 billion. Danaher had a return on equity of 12.38% and a net margin of 12.84%. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.08 EPS. On average, equities research analysts forecast that Danaher will post $3.95 earnings per share for the current fiscal year.
DHR has been the subject of several recent analyst reports. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $96.00 target price for the company in a report on Tuesday, April 4th. Jefferies Group LLC upped their target price on Danaher from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, February 1st. Vetr lowered Danaher from a “strong-buy” rating to a “buy” rating and set a $89.84 target price for the company. in a report on Thursday, January 12th. Evercore ISI upped their target price on Danaher from $88.50 to $91.50 and gave the company a “buy” rating in a report on Tuesday, January 31st. Finally, Citigroup Inc raised Danaher from a “neutral” rating to a “buy” rating and set a $98.00 target price for the company in a report on Friday, February 24th. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Danaher currently has a consensus rating of “Buy” and an average price target of $93.76.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/04/20/danaher-co-dhr-to-issue-quarterly-dividend-of-0-14-on-april-28th-updated-updated.html.
In related news, insider Brian W. Ellis sold 983 shares of the stock in a transaction on Tuesday, February 28th. The stock was sold at an average price of $86.00, for a total value of $84,538.00. Following the transaction, the insider now owns 6,174 shares of the company’s stock, valued at $530,964. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Walter G. Lohr sold 10,578 shares of the stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $84.32, for a total value of $891,936.96. Following the completion of the transaction, the director now directly owns 18,831 shares in the company, valued at approximately $1,587,829.92. The disclosure for this sale can be found here. Insiders sold 60,009 shares of company stock worth $5,106,487 in the last quarter. 12.60% of the stock is currently owned by company insiders.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Co. and related companies with MarketBeat.com's FREE daily email newsletter.